Robert A. Shalwitz
Founder at Invirsa, Inc.
Robert A. Shalwitz active positions
Companies | Position | Start | End |
---|---|---|---|
Invirsa, Inc.
Invirsa, Inc. Medical/Nursing ServicesHealth Services Invirsa, Inc. provides medical services. The company was founded by Robert Shalwitz on November 24, 2014 and is headquartered in Bexley, OH. | Director/Board Member | 2014-11-23 | - |
Chief Executive Officer | 2014-11-23 | - | |
Founder | 2014-11-23 | - | |
President | 2014-11-23 | - |
Career history of Robert A. Shalwitz
Former positions of Robert A. Shalwitz
Companies | Position | Start | End |
---|---|---|---|
AKEBIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2014-01-06 | 2014-08-04 |
Founder | 2007-02-26 | 2014-12-30 | |
Corporate Officer/Principal | 2014-08-04 | 2014-12-30 | |
Sales & Marketing | 2007-02-26 | 2014-01-06 | |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Chief Operating Officer | 2016-03-14 | - |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Chief Tech/Sci/R&D Officer | 2010-12-31 | - |
Founder | 2010-12-31 | - | |
ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - | - |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Chief Tech/Sci/R&D Officer | 2004-12-31 | - |
Training of Robert A. Shalwitz
State University of New York at Buffalo | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Statistics
International
United States | 8 |
Ireland | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Founder | 3 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Invirsa, Inc.
Invirsa, Inc. Medical/Nursing ServicesHealth Services Invirsa, Inc. provides medical services. The company was founded by Robert Shalwitz on November 24, 2014 and is headquartered in Bexley, OH. | Health Services |
- Stock Market
- Insiders
- Robert A. Shalwitz
- Experience